chrisvoncsefalvay/vaers-outcomes huggingface dataset:
started having intermittent headache on 03/08/2021 which he describes as dull pressure starting in his frontal sinuses and working the way posteriorly on both sides.  They are intermittently present and range from 2?5/10 in severity.  No associated photophobia. He has been taking Tylenol at home which provides moderate amount of relief.  He saw a provider on 3/15 and was prescribed high-dose Augmentin at that time which he has been taking without improvement.  He endorses subjective fevers and chills but his body temperature was 99 F.  Mouth ulcers started a few days ago. With that, it became very difficult for him to eat or drink due to excessive pain.   He became concerned because he was also on immunosuppression for transplant and ended up coming to the ER for further evaluation where he was admitted.   Of note, he was switched from Tacrolimus to Sirolimus 3 days prior to his vaccine  3/20 while inpatient, developed fever of 101. Blood cultures negative. Around time of drug changes and vaccine, patient also had a tooth repair.
I got the booster on 5/16/22, I started coming down with symptoms the morning of 05/24/22. I did an at home covid test and it was positive. I called my primary care doctor and got a telemedicine visit the next day and was able to talk with the doctor. The doctor prescribed cough syrup and Paxlovid. I took those as prescribed. I'm not sure of the date I called the doctor back, after finishing Paxlovid I started to feel better but then the next week on 06/08/22 I started to feel bad again. I was still coughing and still testing positive for covid. My doctor prescribed Amoxicillin and waited it out. I finally tested negative on 06/13/22.
ueststarted to develop high heart rate and hypertension....150/100 initially.  started hypertensive therapy.   after second shot on April 8, (Thursday), BP went to 155/108.  had an irregular heart rate...and constrictive feeling around my neck.   thyroid lab studies were abnormal.  my
Golf ball sized round red area surrounding the injection site. Visible needle puncture site-size of a pen ink dot bruising 4 inch itchy rash/redness beginning from edge of raised area traveling down the arm.  No spreading since 6/16/15 (afternoon) & 6/18/15- no spreading-> itchiness today, no swelling just redness & bruising at site of injection. Refer patient to see doctor but pt doesn't want to.
Information has been received from a physician concerning a 68 year old female who in 2007 was vaccinated with Zostavax (Oka/Merck).  In 2007, the patient developed zoster-like rash around her left face and eyelid.  The rash was red and painful with some crusting.  The physician stated that he was prescribing an antiviral medication (therapy unspecified).  The patient was scheduled for evaluation by an ophthalmologist.  The patient's zoster-like rash persisted.  Additional information is not expected.
Severe hypotensive rxn 10min p/inject; complete vasomotor collapse, apnea, cyanosis, frothing @ mouth, stupor, intermittent wailing moaning & crying 15 min rx EPinephrine;
injection site reaction; Rash seems like hives or welts, like 30 of them of each hand and they look like mosquito bites; joint pain; headaches; Rash on the back of both hands; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (injection site reaction), URTICARIA (Rash seems like hives or welts, like 30 of them of each hand and they look like mosquito bites), RASH (Rash on the back of both hands), ARTHRALGIA (joint pain) and HEADACHE (headaches) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: FLU. Past adverse reactions to the above products included No adverse event with FLU.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (low grade fever). On 08-Dec-2021, the patient experienced RASH (Rash on the back of both hands). On an unknown date, the patient experienced VACCINATION SITE REACTION (injection site reaction), URTICARIA (Rash seems like hives or welts, like 30 of them of each hand and they look like mosquito bites), ARTHRALGIA (joint pain) and HEADACHE (headaches). The patient was treated with IBUPROFEN at a dose of 2 cycles 40mg. In November 2021, PYREXIA (low grade fever) had resolved. At the time of the report, VACCINATION SITE REACTION (injection site reaction), URTICARIA (Rash seems like hives or welts, like 30 of them of each hand and they look like mosquito bites), RASH (Rash on the back of both hands), ARTHRALGIA (joint pain) and HEADACHE (headaches) outcome was unknown.            Concomitant product use was not provided by the reporter.    Patient reported he Flu vaccine at the same as the booster   This case was linked to MOD-2021-407187, MOD-2021-407184 (Patient Link).
Bad headache on right lower side of my head.  Itstill hurts now.  Everyday since the shot.
Information has been received from a physician concerning a 15 year old male who on 20-MAY-1996 and 26-JAN-1999 was vaccinated with a first and second dose of MMR II respectively. On 18-JAN-2010 the patient experienced mumps. The patient had stomachache and headache for 2 weeks. The blood work was done on 20-JAN-2010 and the result was not reported. The pumps diagnosed on 20-JAN-2010. At the time of the report, the outcome was not reported. Additional information has been requested.
Telephone call from client with complaint of "fluid filled - pin point spots on neck and R arm". No pain or itching. Benadryl helps. Did not see Dr, if not clearing up will follow-up with Primary doctor and notify our office. 6/14/02 spoke with patient is better since taking Benadryl.
pt came by pharmacy on 10/23/22. just to inform us that he received a fluzone HD on 10/17/22 by RN. He states next am on 10/18/22 he was experiencing pain down his left arm where received injection, he said pain continued to worse. He went to ortho MD who told pt possilby d/t injection. Pt to start PT on Wednesday. Pain is intermittent sometime worse sometimes better. he pointed to back of arm where coming from.pt could not remember where band aid was located i was curious if too high or below armpit where nerve plexus would be. pt is not blaming nurse but wants us to know . pt is very concerned about long term pain. he just retired and concerned will not improve
3-4 hrs p/vax pt started screaming & would not let anyone touch her for 4-6 hrs; pt exp swelling & redness afterwards x 2 days;
Information has been received from a consumer who on an unspecified date was inadvertently vaccinated with the third dose GARDASIL while pregnant. The mother reported that her male child throat was not connected to his stomach, had an esophageal fistula and had imperforated anus. At the time of the report, the outcome of the events was unknown. Upon internal review, throat was not connected to his stomach, esophageal fistula and imperforated anus were considered to be congenital anomalies. The mother's experience is captured in WAES 1006USA04079. Additional information has been requested.
Patient was accidentally given the DTaP vaccine instead of the Tdap vaccine. Patient was notified of mistake. No adverse reaction to date.
Significant headache, body fatigue, and diarrhea.  I took tylonel and watched my diet, symptoms are for most part gone as of this moment.
Weak; Brain felt foggy; Tenderness in her arm; Headache; Chills; Achy joints(wrist, knuckles, and knees); Extremely fatigued; This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (Weak), FEELING ABNORMAL (Brain felt foggy), TENDERNESS (Tenderness in her arm), HEADACHE (Headache) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced ASTHENIA (Weak), FEELING ABNORMAL (Brain felt foggy), TENDERNESS (Tenderness in her arm), HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Achy joints(wrist, knuckles, and knees)) and FATIGUE (Extremely fatigued). At the time of the report, ASTHENIA (Weak), FEELING ABNORMAL (Brain felt foggy), TENDERNESS (Tenderness in her arm), HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Achy joints(wrist, knuckles, and knees)) and FATIGUE (Extremely fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt presents to clinic with right arm redness 10cm x 10cm. Received DTaP in right arm on 05/05/2003. Diagnosed: Localized DTaP reaction. Tx Benadryl, ice pack
Narrative: COVID infection following COVID vaccine series 01/24, Moderna dose #1 02/11, Moderna, dose#2 09/08 pt cc: rhinorrhea, sore throat exposure: travelled 09/10 COVID swab, result: detected 09/10 SARS-COV-2 Variant Sequencing result: pending
Headache, Myalgia, Arthralgia, UrticariaPruritus, left arm soreness
Injection site reaction consisting of discoloration of the area around the injection site to dark brown with no itching, swelling or pain about 4-5 hours after the injection. The size of area is about 1 inch in diameter. The color appears to be lightening over the past two days.
Individual receiving vaccine reported Seizure like event approx. 18 hours after MMR vaccine was given. Stated she had her jaw lock up, very tight and was unable to close her mouth. This was followed by tunnel vision with loss of consciousness for an undetermined amount of time with slight urinary incontinence.  Could not give exact time of how long the symptoms lasted but does not report any residual effects of the event at the time it was reported to me. I strongly advised her to follow up with her Health Care Provider/Neurology for diagnostic examination and future management.
I tested positive for COVID-19 4/07/23. I had a headache, cough, pain in my ear and jaw. I contacted my doctor and was prescribed Paxlovid, Benzonatate, and Mucinex DM. I woke up the next day and I felt very dizzy, and I contacted my doctor, and they told me to rest, and they didn't think it was Paxlovid.
Burning on my face and neck; dryness; local itching/ generalized itching; red eyes; itchy eyes; prickling/ tingling sensation; hoarseness; local rash; spot on my forehead and neck; hypersensitivity reaction; Redness on face and neck,redness,face began to have splotchy red places,local redness; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (spot on my forehead and neck), HYPERSENSITIVITY (hypersensitivity reaction), ERYTHEMA (Redness on face and neck,redness,face began to have splotchy red places,local redness), BURNING SENSATION (Burning on my face and neck) and DRY SKIN (dryness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Previously administered products included for Infection: doxycycline in May 1985. Past adverse reactions to the above products included Redness generalised with doxycycline.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced RASH MACULAR (spot on my forehead and neck), HYPERSENSITIVITY (hypersensitivity reaction), ERYTHEMA (Redness on face and neck,redness,face began to have splotchy red places,local redness), DRY SKIN (dryness), PRURITUS (local itching/ generalized itching), OCULAR HYPERAEMIA (red eyes), EYE PRURITUS (itchy eyes), PARAESTHESIA (prickling/ tingling sensation), DYSPHONIA (hoarseness) and RASH (local rash). On an unknown date, the patient experienced BURNING SENSATION (Burning on my face and neck). The patient was treated with HYDROCORTISONE ongoing from 06-Apr-2021 at an unspecified dose and frequency and TIRBANIBULIN (KLISYRI) at an unspecified dose and frequency. At the time of the report, RASH MACULAR (spot on my forehead and neck) and HYPERSENSITIVITY (hypersensitivity reaction) had not resolved and ERYTHEMA (Redness on face and neck,redness,face began to have splotchy red places,local redness), BURNING SENSATION (Burning on my face and neck), DRY SKIN (dryness), PRURITUS (local itching/ generalized itching), OCULAR HYPERAEMIA (red eyes), EYE PRURITUS (itchy eyes), PARAESTHESIA (prickling/ tingling sensation), DYSPHONIA (hoarseness) and RASH (local rash) outcome was unknown.            Concomitant medication of the patient was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Patient information, past medical history, suspect drug dosage details, facility information were updated. New events of rash macular, hypersensitivity, dry skin, pruritus, ocular hyperaemia, eye pruritus, paranesthesia, dysphonia and rash were added. On 04-Aug-2021: Follow-up information included no new information. On 04-Aug-2021: Follow-up information included no new information.
Pneumovax administered in R arm-developed cellulitis and was Rx with antibiotics Keflex-swelling and redness at site given on 5/30 UC on 5/31-6/1-6/2-pcp on 6/3.
parotitis mild/mod pain w/swelling;non-supportive 1mo p/vax;
Pain in my lower right back; Bloated stomach; Having gas; Warmth in upper body; Feeling cold; Pain in right hip; I also experienced a funny tingling feeling under my left arm pit; Sore left arm; Nauseated; Pain on the right side of breast; Pain in my pelvis area; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 05May2021 at 10:30 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension, arthritis, pre-diabetic and known allergies to peanuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. On 05May2021 at 10:50, 20 minutes after getting the Pfizer vaccine injection, the patient began to have pain in her pelvis area that felt like menstrual cramps or labor pain. The pain came every 15 minutes and lasted all day and evening. The patient took naproxen sodium (ALEVE) at night to relieve the pain. The next day, she did not feel the pain in the pelvis area. On 05May2021 at 11:00, the patient continued to have pain in her lower right back and in right hip for a whole month. The patient also experienced a funny tingling feeling under her left arm pit and continued to do so; it was a strange feeling that comes and go away quickly. The patient experienced the tingling feeling every day. The other symptoms disappeared within four days; such as pain on the right side of breast, sore left arm, warmth in upper body, feeling cold, nauseated, had gas and bloated stomach. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event pain in her pelvic area which included treatment with naproxen sodium (ALEVE) from an unknown date to unknown date. The clinical outcome of the events pain in her pelvis area was resolved with sequelae on an unknown date in 2021, pain in her lower right back, pain in right hip was resolved with sequelae on an unknown date in Jun2021, funny tingling feeling under her left arm pit was not resolved, whereas the clinical outcome of the events pain on the right side of breast, sore left arm, warmth in upper body, feeling cold, nauseated, had gas and bloated stomach were resolved on an unknown date in May2021.
Cough/productive of mostly clear but sometimes yellow mucous; Steady wheeze; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (Cough/productive of mostly clear but sometimes yellow mucous) and WHEEZING (Steady wheeze) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PRODUCTIVE COUGH (Cough/productive of mostly clear but sometimes yellow mucous) and WHEEZING (Steady wheeze). The patient was treated with PREDNISONE for Cough, at a dose of 40 milligram. At the time of the report, PRODUCTIVE COUGH (Cough/productive of mostly clear but sometimes yellow mucous) had resolved and WHEEZING (Steady wheeze) had not resolved.            No concomitant medications were reported.  Treatment medications also included an unspecified antibiotic for the cough and patient also got an inhaler which helped her with cough and wheezing.   Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2021: Significant Follow-up received, included Relevant Medical history, outcome of event (productive cough) was updated, additional treatment for both the events were added.
Initial information received on 08-Feb-2019 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 16 years old male patient received vaccine MENACTRA instead of MENINGOCOCCAL VACCINE B. The patients past medical history, concomitant medication and family history were not provided. On unknown date in May 2014, the patient received a first dose of suspect MENACTRA lot number not reported via unknown route in unknown administration site. On 17-May-2018 he also received a second Booster dose of the same vaccine with an unknown batch number via unknown route in unknown administration site and On 05-Feb-2019 patient also received a third dose 0.5ml of the same vaccine lot U6179AA, expiry 29-Mar-2020 via unknown route in the right deltoid instead of suspect MENINGOCOCCAL VACCINE B not produced by Sanofi Pasteur lot number not reported via unknown route in unknown administration site. It was an actual medication error due to wrong vaccine administered and extra dose administered. It was reported that order was documented as meningitis immunization and nurse did not realize patient had been scheduled for meningitis B vaccine instead patient receiving a third MENACTRA vaccine. The patient did not experience any adverse reaction after the injection. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
Nausea; loss of appetite; unintended weight loss; chronic fatigue; weakness; light headed; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCIBE Solution for injection Lot Number: EN6207) via an unspecified route of administration in arm left on 23Mar2021 as dose 1, single and bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: EW0158) via an unspecified route of administration in arm right on 23Mar2021 as dose 2, single (age at vaccination: 59 years) for COVID-19 immunisation. Medical history included COPD, fibromyalgia, depression, allergies, all from an unknown date and unknown if ongoing. Concomitant medications were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. No COVID prior vaccination and tested COVID post vaccination. On 23Mar2021 12:00 PM, the patient experienced nausea, loss of appetite, unintended weight loss, chronic fatigue, weakness, light headed. The adverse event resulted in doctor or other healthcareprofessional office/clinic visit. Treatment received was medication endoscopy colonoscopy MRI. The patient underwent lab tests and procedures which included sars-cov-2 test resulted as negative on 09May2021, MRI resulted as unknown on an unknown date, endoscopy resulted as unknown on an unknown date, colonoscopy resulted as unknown on an unknown date. The clinical outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Patient received dose 2/5/2021 - On 2/6/2021, patient with sore arm managed with Tylenol.  Resolved until 2/13 when patient developed arm swelling from shoulder to elbow.  Red Blotch 2"x2", and feverish..  Patient went to immediate care on 2/15 and diagnosied with cellulitis and infection.  Prescribed SMX/TMP and Clindamycin for infection.   Follow-up with primary physician 2/19 pending.
Information has been received from a physician concerning a female in her 60s with pulmonary problems who on 8/3/05 was vaccinated SC with a dose of pneumococcal 23v polysaccharide vaccine. On approximately 8/3/05, the patient developed a severe local reaction to pneumococcal 23v polysaccharide vaccine, including swelling, edema, erythema, localized urticaria, fever, and severe pain. Medical attention was sought. The patient was recovering. The reporting physician considered the events to be disabling. Additional information has been requested.
Patient reports to this nurse fatigue, inability to lift left arm (injected arm), swollen lymph to left axilla, severe abdominal pain, diarrhea, dizziness, chills, fever 100.3 and moderate headache. Patient states that she took Alka Seltzer and improving improving today.
Erythema, itching, swelling at injection site (15 cm x 8 cm).
Had minor swelling/tenderness at injection site within first 24 hours. Then today, 8 days after first modern injection, injection site has swollen larger than first time and is warm, itchy, and tender.